Guggenheim Capital’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-4,779
| Closed | -$234K | – | 2839 |
|
|
2016
Q4 | $234K | Sell |
4,779
-465
| -9% | -$22.8K | ﹤0.01% | 2660 |
|
|
2016
Q3 | $251K | Sell |
5,244
-186
| -3% | -$8.9K | ﹤0.01% | 2603 |
|
|
2016
Q2 | $291K | Buy |
5,430
+141
| +3% | +$7.56K | ﹤0.01% | 2552 |
|
|
2016
Q1 | $237K | Buy |
+5,289
| New | +$237K | ﹤0.01% | 2635 |
|
|
2015
Q4 | – | Sell |
-53,201
| Closed | -$1.69M | – | 2987 |
|
|
2015
Q3 | $1.69M | Buy |
53,201
+539
| +1% | +$17.2K | 0.01% | 1721 |
|
|
2015
Q2 | $1.74M | Buy |
52,662
+13,411
| +34% | +$443K | ﹤0.01% | 1871 |
|
|
2015
Q1 | $1.62M | Buy |
39,251
+8,069
| +26% | +$332K | ﹤0.01% | 1949 |
|
|
2014
Q4 | $1.27M | Sell |
31,182
-2,057
| -6% | -$83.8K | ﹤0.01% | 2067 |
|
|
2014
Q3 | $1.22M | Sell |
33,239
-7,223
| -18% | -$265K | ﹤0.01% | 2079 |
|
|
2014
Q2 | $1.87M | Sell |
40,462
-5,083
| -11% | -$235K | ﹤0.01% | 1849 |
|
|
2014
Q1 | $1.87M | Sell |
45,545
-14,990
| -25% | -$616K | 0.01% | 1814 |
|
|
2013
Q4 | $2.31M | Buy |
+60,535
| New | +$2.31M | 0.01% | 1619 |
|